Search Results
Viewing: 201-210 of 263 | All
News
Gail Besner, MD, Named 2024 Allen Distinguished Scholar in Pediatric Research
Gail Besner, MD, chief of Pediatric Surgery and principal investigator in the Center for Perinatal Research in the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital, was named the 2024 Allen Distinguished Scholar in Pediatric Research. The award is given in honor of former Nationwide Children’s CEO, Steve Allen, MD, and his role in growing the AWRI into a preeminent research institution.
Article
Community Provider Corner
- Support Confident Vaccine Conversations
- Oral Health Matters
- Mobile Health Locator App
- Boost Kindergarten Readiness
- Free Courses Available on the Behavioral Health Learning Library
- Community Education Offerings
- Christine Thomas Selected to Serve on Statewide Maternal and Infant Health Leadership Council
News
Nationwide Children’s Hospital Launches “Empower the Possible” Campaign with Historic 10-Year, $100 Million Commitment from Nationwide Foundation
Nationwide Children’s Hospital is honored to announce that it has received a historic 10-year commitment of $100 million from the Nationwide Foundation. This landmark announcement marks the public launch of the hospital’s “Empower the Possible” campaign that with other gifts brings the campaign’s fundraising total to more than $270 million, more than halfway to the campaign goal of $500 million.
News
Nationwide Children’s Hospital Researcher Lauren Bakaletz, PhD, Honored by AAAS as Lifetime AAAS Fellow
The American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals, has elected Lauren Bakaletz, PhD, director of the Center for Microbial Pathogenesis in the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital to the newest class of AAAS Fellows, among the most distinct honors within the scientific community.
News
Study Finds Teens Driving Older Vehicles Have Increased Risk for Fatal Crashes
Motor vehicle crashes are the leading cause of death for U.S. teens. Newer vehicles and driver assistance technologies show promise in reducing crashes and injury severities. Researchers at Nationwide Children’s Hospital reviewed national fatal crash data (2016-2021) and examined the vehicle age and driver assistance technologies of vehicles driven by teen and middle-aged drivers, and their associations with driver deaths during fatal crashes.
News
New Study Highlights Urgent Need for Targeted Suicide Prevention and Mental Health Support for Sexual and Gender Diverse Youth
Researchers from the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital analyzed six years of multistate child death review data from the United States and found that 81% of sexual and gender diverse youth in the dataset died by suicide, despite many receiving current or prior mental health services.
News
FDA Grants Nationwide Children’s Hospital Researchers Safe-To-Proceed Authorization on First-In-World CAR-NK Cells Made with CRISPR/AAV
Researchers at Nationwide Children’s Hospital have received safe-to-proceed approval from the Food and Drug Administration (FDA) for Universal-Donor CD38KO CD33CAR-NK cells, to be studied in a forthcoming clinical trial. The Phase 1 trial will study the safety of the novel therapy in patients with advanced, high-risk acute myeloid leukemia (AML).
News
New Insights into the Role of the NOTCH1 Gene in Congenital Heart Defects
A new study published in Circulation Research provides novel insights into how mutations in the NOTCH1 gene may lead to abnormal differentiation and proliferation of cardiomyocytes and contribute to ventricular hypoplasia and other structural anomalies found in congenital heart defects in humans.
News
Human MicroRNA Inhibits Expression of Pathogenic Gene Underlying Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is caused by aberrant expression of the DUX4 gene in skeletal muscles. Researchers at Nationwide Children’s Hospital have recently demonstrated that an endogenous human microRNA, miR-675, inhibits DUX4 expression and protects muscles from DUX4-mediated cell death in a mouse model when administered via gene therapy. They also showed that the small molecule-based treatments that upregulate miR-675 inhibited DUX4 mRNA and DUX4-associated biomarkers in myotubes derived from patients with FSHD.
News
Study Finds Adolescents with Concussion May Benefit from More Activity Earlier
Researchers at Nationwide Children’s Hospital have found that when it comes to concussion recovery, activity type matters. In a study published today in British Journal of Sports Medicine, researchers found that limiting screen time and returning to school early following a concussion may speed up recovery.